ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED
- Legal registered address
- Envision House 5 North Street Horsham West Sussex RH12 1XQ Copied!
Current company directors
DEUTSCH, Adam Brent, Mr.
GILLIE, John David
HEIM, Margaret
HOLLIS KORTH, Joshua
LADRIERE, BRUNO SERGE LEON
MILLER III, Howard Collins
MORTIMER, Michael Irvine
PONTI, Andrea
RUDNICK, Stanford Benjamin
SETTON, DANIEL JACQUES JOSEPH ALEXANDRE
WITCHER, BENJAMIN MAURICE FREDERICK
View full details of company directors- Company number
- 10138701 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 20 April 2025
Next statement due by 4 May 2026
Nature of business (SIC)
74909 - Other professional, scientific and technical activities not elsewhere classified
Previous company names
| Name | Date previous name changed |
|---|---|
| TYROL ACQUISITIONCO LIMITED | 2 March 2017 |
Latest company documents
| Date | Description |
|---|---|
| 22/04/2522 April 2025 | Confirmation statement made on 2025-04-20 with no updates |
| 28/02/2528 February 2025 | Director's details changed for Stanford Benjamin Rudnick on 2024-12-09 |
| 10/02/2510 February 2025 | Appointment of Stanford Benjamin Rudnick as a director on 2024-12-09 |
| 24/01/2524 January 2025 | Termination of appointment of Joshua Hollis Korth as a director on 2024-11-15 |
| 24/01/2524 January 2025 | Termination of appointment of Howard Collins Miller Iii as a director on 2024-12-31 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company